Crystallization of a trimeric human T cell leukemia virus type 1 gp21 ectodomain fragment as a chimera with maltose-binding protein

Protein Science

Volumn 7, Issue 7, 1998, Pages 1612-1619

  Center, Rob J ^a   Kobe, Bostjan ^a   Wilson, Kirilee A ^a   Teh, Trazel ^a   Howlett, Geoffrey J ^b   Kemp, Bruce E ^a   Poumbourios, Pantelis ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

E. coli protein expression; Maltose binding protein HTLV 1 gp21 chimera; Protein crystallization; Trimerization; X ray diffraction

Indexed keywords

HYBRID PROTEIN; MALTOSE;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHIMERA; CRYSTALLIZATION; ESCHERICHIA COLI; HUMAN T CELL LEUKEMIA VIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEDIMENTATION RATE; X RAY DIFFRACTION;

ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; MAMMALIA;

EID: 0031824806     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560070715     Document Type: Article

References (46)

1. Abacioglu YH, Fouts TR, Laman JD, Claassen E, Pincus SH, Moore JP, Roby CA, Kamin-Lewis R, Lewis GK. 1994. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res Hum Retroviruses 10:371-381.
2. Air GM, Webster RG, Colman PM, Laver WG. 1987. Distribution of sequence differences in influenza N9 neuraminidase of tern and whale viruses and crystallization of the whale neuraminidase complexed with antibodies. Virology 160:346-354.
3. Blaber M, Zhang X-J, Lindstrom JD, Pepiot SD, Baase WA, Matthews BW. 1994. Determination of α-helical propensity within the context of a folded protein. J Mol Biol 235:600-624.
4. Blacklow SC, Lu M, Kim PS. 1995. A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry 34:14955-14962.
5. Bullough PA, Hughson FM, Skehel JJ, Wiley DC. 1994. Structure of influenza hemagglutinin at the pH of membrane fusion. Nature 371:37-43.
6. Carter DC, Rüker F, Ho JX, Lim K, Keeling K, Gilliland G, Ji X. 1994. Fusion proteins as alternate crystallization paths to difficult structure problems. Protein Pept Lett 1:175-178.
7. CCP4. 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D50:760-763.
8. Center RJ, Kemp BE, Poumbourios P. 1997. Human immunodeficiency virus type 1 and 2 envelope glycoproteins oligomerize through conserved sequences. J Virol 71:5706-5711.
9. Chan DC, Fass D, Berger JM, Kim PS. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-273.
10. Delamarre L, Rosenberg AR, Pique C, Pham D, Callebaut I, Dokhélar M-C. 1996. The HTLV-I envelope glycoproteins: Structure and functions. J Acq Immun Defic Syndrome Hum Retrovirol 13 Suppl 1:S85-S91.
11. Delamarre L, Rosenberg AR, Pique C, Pham D, Dokhélar M-C. 1997. A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity. J Virol 71:259-266.
12. Donahue JP, Patel H, Anderson WF, Hawiger J. 1994. Three-dimensional structure of the platelet integrin recognition segment of the fibrinogen γ chain obtained by carrier protein-driven crystallization. Proc Natl Acad Sci USA 91:12178-12182.
13. Donegan E, Lee H, Operskalski GM, Shaw GM, Kleinman SH, Busch MP, Stevens CE, Schiff ER, Nowicki MJ, Hollingsworth CG, Mosley JW, Transfusion Safety Study Group. 1994. Transfusion transmission of retroviruses: Human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion 34:478-483.
14. Earl PL, Hügin AW, Moss B. 1990. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. J Virol 64:2448-2451.
15. Einfeld DA, Hunter E. 1994. Expression of the TM protein of Rous sarcoma virus in the absence of SU shows that this domain is capable of oligomerization and intracellular transport. J Virol 68:2513-2520.
16. Fan N, Gavalchin J, Paul B, Wells K, Lane MJ, Poiesz B. 1992. Infection of peripheral blood mononuclear cells and cell lines by cell-free human T cell lymphoma/leukemia virus type I. J Clin Microbiol 30:905-910.
17. Fass D, Harrison SC, Kim PS. 1996. Retrovirus envelope domain at 1.7 Å resolution. Nat Struct Biol 3:465-469.
18. Fass D, Kim PS. 1995. Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin. Curr Biol 5:1377-1383.
19. Gallaher WR, Ball JM, Garry RF, Griffin MC, Montelaro RC. 1989. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res Hum Retroviruses 5:431-440.
20. Heinz DW, Baase WA, Matthews BW. 1992. Folding and function of a T4 lysozyme containing 10 consecutive alanines illustrate the redundancy of information in an amino acid sequence. Proc Natl Acad Sci USA 89:3751-3755.
21. Jacobo-Molina A, Clark AD Jr, Williams RL, Nanni RG, Clark P, Ferris AL, Hughes SH, Arnold E. 1991. Crystals of a ternary complex of human immunodeficiency virus type 1 reverse transcriptase with a monoclonal antibody Fab fragment and double-stranded DNA diffract X-rays to 3.5-Å resolution. Proc Natl Acad Sci USA 88:10895-10899.
22. Jancarik J, Kim S-H. 1991. Sparse matrix sampling: A screening method for crystallization of proteins. J Appl Crystallogr 24:409-411.
23. Jones TA, Bergdoll M, Kjeldgaard M. 1990. O: A macromolecule modeling environment. In: Bugg CE, Ealick SE, eds. Cristallographic and modeling methods in molecular design. New York: Springer Verlag. pp 189-195.
24. Kobe B, Jennings IG, House CM, Feil SC, Michell BJ, Tiganis T, Parker MW, Cotton RGH, Kemp BE. 1997. Regulation and crystallization of phosphorylated and dephosphorylated forms of truncated dimeric phenylalanine hydroxylase. Protein Sci 6:1352-1357.
25. Kuge M, Fujii Y, Shimizu T, Hirose F, Matsukage A, Hakoshima T. 1997. Use of a fusion peptide to obtain crystals suitable for X-ray analysis: Crystallization of a GST-fused protein containing the DNA-binding domain of DNA replication-related element-binding factor, DREF. Protein Sci 6:1783-1786.
26. Lim K, Ho JX, Keeling K, Gilliland GL, Ji X, Rüker F, Carter DC. 1994. Three-dimensional structure of Schistosoma japonicum glutathione S-transferase fused with a six-amino acid conserved neutralizing epitope of gp41 from HIV. Protein Sci 3:2233-2244.
27. Lu M, Blacklow SC, Kim PS. 1995. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol 2:1075-1082.
28. Matthews BW. 1968. Solvent content of protein crystals. J Mol Biol 33:491-497.
29. McPherson A. 1982. Preparation and analysis of protein crystals. New York: John Wiley and Sons.
30. Ostermeier C, Iwata S, Ludwig B, Michel H. 1995. Fv fragment-mediated crystallization of the membrane protein bacterial cytochrome c oxidase. Nat Struct Biol 2:842-846.
31. Otwinowski Z. 1993. Data collection and processing. In: Sawyer L, Isaacs N, Bailey S, eds. Proceedings of the CCP4 study weekend. Daresbury, UK: SERC Daresbury Laboratory. pp 56-62.
32. Paine E, Garcia J, Philpott TC, Shaw G, Ratner L. 1991. Limited sequence variation in human T-lymphotrophic virus type 1 isolates from North American and African patients. Virology 182:111-123.
33. Paine E, Gu R, Ratner L. 1994. Structure and expression of the human T-cell leukemia virus type 1 envelope protein. Virology 199:331-338.
34. Pancino G, Camoin L, Sonigo P. 1995. Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein. J Virol 69:2110-2118.
35. Pique C, Pham D, Tursz T, Dokhélar M-C. 1992. Human T-cell leukemia virus type 1 envelope protein maturation process: Requirements for syncytium formation. J Virol 66:906-913.
36. Poumbourios P, Wilson KA, Center RJ, El Ahmar W, Kemp BE. 1997. Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic α-helical/leucine zipper-like sequence. J Virol 71:2041-2049.
37. Prongay AJ, Smith TJ, Rossmann MG, Ehrlich LS, Carter CA, McClure J. 1990. Preparation and crystallization of a human immunodeficiency virus p24-Fab complex. Proc Natl Acad Sci USA 87:9980-9984.
38. Rost B. 1996. PHD: Predicting one-dimensional protein structure by profiles-based neural networks. Methods Enzymol 266:525-559.
39. Spurlino JC, Lu G-Y, Quiocho FA. 1991. The 2.3-Å resolution structure of the maltose-or maltodextrin-binding protein, a primary receptor of bacterial active transport and chemotaxis. J Biol Chem 266:5202-5219.
40. Syu W-J, Lee W-R, Du B, Yu Q-C, Essex M, Lee T-H. 1991. Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity. J Virol 65:6349-6352.
41. Tan K, Liu J-H, Wang J-H, Shen S, Lu M. 1997. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci USA 94:12303-12308.
42. Thomas A, Roth MJ. 1995. Analysis of cysteine mutations on the transmembrane protein of Moloney murine leukemia virus. Virology 211:285-289.
43. Weissenhorn W, Calder LJ, Dessen A, Laue T, Skehel JJ, Wiley DC. 1997a. Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli. Proc Natl Acad Sci USA 94:6065-6069.
44. Weissenhorn W, Dessen A, Harrison SC, Skehel JJ, Wiley DC. 1997b. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387:426-430.
45. Wilson IA, Skehel JJ, Wiley DC. 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289:366-373.
46. Wingfield PT, Stahl SJ, Kaufman J, Zlotnick A, Hyde CC, Gronenborn AM, Clore GM. 1997. The extracellular domain of immunodeficiency virus gp41 protein: Expression in Escherichia coli, purification, and crystallization. Protein Sci 6:1653-1660.